Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
Olbetam 250 mg Capsules.
| Pharmaceutical Form |
|---|
|
Red-brown/dark pink hard gelatin capsules, size no. 1, containing a white to cream powder. |
Acipimox 250.00 mg.
For the full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acipimox |
Acipimox inhibits the release of fatty acids from adipose tissue and reduces the blood concentrations of very low density lipoproteins (VLDL or Pre-beta) and low density lipoproteins (LDL or beta) with a subsequent overall reduction in triglyceride and cholesterol levels. |
| List of Excipients |
|---|
|
Physically modified corn starch (STA-RX 1500) Hard gelatin capsules shell: Gelatin |
Packed in blisters of 10 capsules per strip, inside cartons. Each carton contains 90 capsules.
Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
PL 00057/1022
2 May 2003
| Drug | Countries | |
|---|---|---|
| OLBETAM | Netherlands, New Zealand, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
